Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain.

Babbar S, Marier JF, Mouksassi MS, Beliveau M, Vanhove GF, Chanda S, Bley K.

Ther Drug Monit. 2009 Aug;31(4):502-10. doi: 10.1097/FTD.0b013e3181a8b200.

PMID:
19494795
2.

Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.

Simpson DM, Gazda S, Brown S, Webster LR, Lu SP, Tobias JK, Vanhove GF; NGX-4010 C118 Study Group.

J Pain Symptom Manage. 2010 Jun;39(6):1053-64. doi: 10.1016/j.jpainsymman.2009.11.316.

PMID:
20538187
3.

An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.

Simpson DM, Estanislao L, Brown SJ, Sampson J.

J Pain Symptom Manage. 2008 Mar;35(3):299-306. Epub 2007 Oct 23.

PMID:
17959343
4.

NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain.

Noto C, Pappagallo M, Szallasi A.

Curr Opin Investig Drugs. 2009 Jul;10(7):702-10.

PMID:
19579176
6.

Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.

Webster LR, Peppin JF, Murphy FT, Lu B, Tobias JK, Vanhove GF.

Diabetes Res Clin Pract. 2011 Aug;93(2):187-97. doi: 10.1016/j.diabres.2011.04.010. Epub 2011 May 25.

PMID:
21612836
7.

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension.

Backonja MM, Malan TP, Vanhove GF, Tobias JK; C102/106 Study Group.

Pain Med. 2010 Apr;11(4):600-8. doi: 10.1111/j.1526-4637.2009.00793.x. Epub 2010 Jan 22.

PMID:
20113411
8.

NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia.

Irving G, Backonja M, Rauck R, Webster LR, Tobias JK, Vanhove GF.

Clin J Pain. 2012 Feb;28(2):101-7. doi: 10.1097/AJP.0b013e318227403d.

PMID:
21753727
9.

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.

Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan P Jr, Rauck R, Tobias J; NGX-4010 C116 Study Group.

Lancet Neurol. 2008 Dec;7(12):1106-12. doi: 10.1016/S1474-4422(08)70228-X. Epub 2008 Oct 30. Erratum in: Lancet Neurol. 2009 Jan;8(1):31.

PMID:
18977178
10.

A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.

Webster LR, Malan TP, Tuchman MM, Mollen MD, Tobias JK, Vanhove GF.

J Pain. 2010 Oct;11(10):972-82. doi: 10.1016/j.jpain.2010.01.270. Epub 2010 Jul 24.

PMID:
20655809
11.

Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.

Simpson DM, Brown S, Tobias J; NGX-4010 C107 Study Group.

Neurology. 2008 Jun 10;70(24):2305-13. doi: 10.1212/01.wnl.0000314647.35825.9c.

PMID:
18541884
12.

Developmental toxicity study of pure trans-capsaicin in rats and rabbits.

Chanda S, Sharper V, Hoberman A, Bley K.

Int J Toxicol. 2006 May-Jun;25(3):205-17.

PMID:
16717036
13.

A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.

Irving GA, Backonja MM, Dunteman E, Blonsky ER, Vanhove GF, Lu SP, Tobias J; NGX-4010 C117 Study Group.

Pain Med. 2011 Jan;12(1):99-109. doi: 10.1111/j.1526-4637.2010.01004.x. Epub 2010 Nov 18.

PMID:
21087403
14.

Capsaicin 8% topical patch (Qutenza)--a review of the evidence.

Jones VM, Moore KA, Peterson DM.

J Pain Palliat Care Pharmacother. 2011;25(1):32-41. doi: 10.3109/15360288.2010.547561.

PMID:
21426216
15.

Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.

Joerger M, Huitema AD, Meenhorst PL, Schellens JH, Beijnen JH.

Cancer Chemother Pharmacol. 2005 May;55(5):488-96. Epub 2005 Feb 23.

PMID:
15726371
16.

Topical capsaicin in the management of HIV-associated peripheral neuropathy.

Paice JA, Ferrans CE, Lashley FR, Shott S, Vizgirda V, Pitrak D.

J Pain Symptom Manage. 2000 Jan;19(1):45-52.

PMID:
10687326
18.

A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia.

Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E.

Clin Ther. 1993 May-Jun;15(3):510-26.

PMID:
8364943
19.

NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.

Simpson DM, Brown S, Tobias JK, Vanhove GF; NGX-4010 C107 Study Group.

Clin J Pain. 2014 Feb;30(2):134-42. doi: 10.1097/AJP.0b013e318287a32f.

PMID:
23446088
20.

Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.

Persiani S, D'Amato M, Makovec F, Tavares IA, Bishai PM, Rovati LC.

Int J Clin Pharmacol Ther. 2002 May;40(5):198-206.

PMID:
12051571

Supplemental Content

Support Center